Azalea Therapeutics

Biotechnology · Berkeley, CA · Founded 2023 · Privately Held (backing)

Operator of a biotechnology platform intended to enable precise genome editing inside the body for disease treatment. Azalea Therapeutics is based in Berkeley, CA and was founded in 2023. It was valued at $153 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $82 million across 1 recorded round; the latest was a $65 million Series A in Oct 2025.

PMV mark · valuation
$153.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$82.0M
Last round
Early Stage VC (Series A)
Oct 2025

Who backs Azalea Therapeutics?

6 investors
InvestorType
RA Capital ManagementAsset manager
University of CaliforniaOther
Sozo VenturesVenture capital
Third Rock VenturesVenture capital
Berkeley—
Yosemite—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Azalea Therapeutics investors

6 investors are on record for Azalea Therapeutics, including RA Capital Management, University of California, Sozo Ventures and Third Rock Ventures. The Series A in Oct 2025 drew 3 investors.

Free account
More of Azalea Therapeutics with a free account
  • ·Watch Azalea Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Azalea Therapeutics in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View